There aren’t many things that my husband and I fight over, but the JBL Clip 5 is on that list. I normally win the custody battle, which is why you can almost always find it in my bag (along with ...

Community volunteer Alfie Malone and reporter Kristen Griffith both struggled with what to make of an offensive audio clip that turned out to be fake When an audio clip appeared to show a local ...

Throughout the world, an estimated 800 million people consider cassava root a staple part of their diet. This starchy tuber—also known as yuca, Brazilian arrowroot, and manioc—first originated in ...

Studies that once seemed to support the drug, simufilam, have been called into question, leading to retractions from scientific journals and resignations of top officials at Cassava Sciences ...

Create wow-worthy images with your words and AI with Designer, and try Copilot, your AI-powered search assistant for the web. Key takeaways Designer is an AI-powered art generator integrated into ...

Cassava Sciences and two former executives agreed to pay more than $40 million in a settlement with the SEC. The SEC said that Cassava made misleading statements about a clinical trial of its ...

Although Nigeria is ranked number one in cassava production globally, she imported about $54,200 in cassava in 2022, becoming the 121st largest importer of cassava in the world. This was disclosed ...

A former Alzheimer’s researcher manipulated the results of a Cassava Sciences drug, with the pharmaceutical company and its former chief executive reaching a $40 million settlement with the Securities ...

Cassava Sciences (NASDAQ:SAVA) has agreed to pay $40M to settle charges by the U.S. Securities and Exchange Commission (SEC) that the drug developer made misleading claims about the 2020 trial ...

Cassava Sciences has agreed to pay $40 million to resolve an investigation into claims it made misleading statements about phase 2b data on its Alzheimer’s disease drug candidate. The U.S ...

AUSTIN, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (“Cassava” or the “Company”) (Nasdaq: SAVA), a biotechnology company focused on ...